Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Avatar Builder | Contact Info | Update Email | Update Password | Leaderboards | Manage Favourite | Reputation | Reputation History | Subscriptions | Payment Info | Invoices | Favourites

Bullboard Post History

by SallySa

Order by:

PLM.R.W	Kevin Harrington Discusses FSD Pharma {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... April 13, 2023
MA	Kevin Harrington Discusses FSD Pharma {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... April 13, 2023
PLM.R.W	FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On... July 15, 2022
MA	FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On... July 15, 2022
MA	FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... June 3, 2022
PLM.R.W	FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... June 3, 2022
PLM.R.W	FSD Pharma Files Investigational New Drug Application “IND” FSD Pharma Files Investigational New Drug Application (“IND”) with... June 2, 2022
MA	FSD Pharma Files Investigational New Drug Application “IND” FSD Pharma Files Investigational New Drug Application (“IND”) with... June 2, 2022
MA	FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets ... May 11, 2022
PLM.R.W	FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets ... May 11, 2022
MA	Lucid-MS for Multiple Sclerosis Treatment {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... May 3, 2022
PLM.R.W	FSD Pharma Inc: Lucid MS Video {^youtubevideo\|(width)560\|(height)340\|(rel)False\|(url)https://www.youtube.com... April 30, 2022
MA	"Julia Levy Award" Recipient David Allan and Dr. John McGraw FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John... April 26, 2022

Featured Company

Xcyte Digital Corp. V.XCYT

Xcyte Digital is a virtual event company focused on simplifying the event hosting industry and expanding event hosting ... view more »